A Win For ALZN
Tue, Dec 14, 2021 at 05:30 PM
ALZN (ALZN:NASDAQ) soared at $3.08, representing a gain of 28.3%. On Mon, Dec 13, 2021, ALZN:NASDAQ touched a New 2-Week High of $2.4. The stock got featured on our News Catalysts scanner on Tue, Nov 30, 2021 at 09:35 AM in the 'BIOTECH' category. From Mon, Nov 29, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Sep 30, 2021 at $3.57 with a volume of 58M+.
About ALZN (ALZN:NASDAQ)
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.
Top 10 Gainers:
- Galera Therapeutics, Inc. (GRTX:NASDAQ), 95.65%
- Mitcham Industries, Inc. (MIND:NASDAQ), 29.93%
- ALZN (ALZN:NASDAQ), 28.33%
- RPHM (RPHM:NASDAQ), 23.84%
- VLON (VLON:NASDAQ), 22.02%
- CPS Technologies Corporation (CPSH:NASDAQ), 20.49%
- EBON (EBON:NASDAQ), 20.16%
- TMX (TMX:NYSE), 18.02%
- BBAI (BBAI:NYSE), 17.73%
- BIRD (BIRD:NASDAQ), 17.59%